Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase-producing Enterobacterales Undergoing Liver Transplantation
NCT07759453Phase 3Not yet recruiting
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Oct 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 3 trial of ceftazidime + avibactam, meropenem + vaborbactam, imipenem + cilastatin + relebactam, cefiderocol, aztreonam in Enterobacterales infection, sponsored by Sant'Orsola-Malpighi University Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
ceftazidime + avibactammeropenem + vaborbactamimipenem + cilastatin + relebactamcefiderocolaztreonam
03
Conditions
Enterobacterales infection
Beyond the preview
Go deeper on NCT07759453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759453.